[PR-Canada.net] — At the Federal Sleep Institute, identifying Americans with Obstructive Sleep Apnea (OSA) is our first priority. Undiagnosed OSA affects up to 15% of our entire population, making it a significant medical problem that can be the source of: obesity, high blood pressure, depression, erectile dysfunction, excessive daytime sleepiness, irritability, and poor work performance. Moreover, with a staggering amount of large vehicle accidents attributed to sleep apnea every year, now is the time to provide a comprehensive solution for sleep apnea suffers.
Our patented service is broken down into the follow steps. First, we gather your sleep apnea information and symptoms via an online survey or online PDF. Next, we pass that information onto your local authorized doctor within 24 hours. Then your local state doctor assesses your symptoms, meets with you, and then prescribes a sleep apnea at-home study, sent to your house by the Federal Sleep Institute. Once we receive your results from the test, we share those with your doctor; in turn, the doctor prescribes the treatment plan, which is then forwarded immediately back to you. You then can purchase your CPAP device.
Also, we understand that successful treatment is critical in for a good night’s sleep…that’s why we offer compliance services to ensure that you have the information needed for your doctor. This service includes reviewing your CPAP therapy data and maintaining your therapeutic history for employers or the DOT, for example.
Overall, untreated OSA is an enormous liability from a safety standpoint, use our compliance services to help limit your exposure. Untreated sleep apnea is a problem. Our system is the solution.
About Federal Sleep Institute
The Federal Sleep Institute is committed to helping you achieve true, restful, and rejuvenating sleep through providing you with a home sleep study and offering CPAP devices.
Article provided by the Federal Sleep Institute. Please visit our Web site at http://www.federalsleepinstitute.com.

You must be logged in to post a comment.